Autologous stem cell therapy ( Lifecells LLC)

N/A

Report date: 2023/02/18 19:46:34

Base Information

Drug NameAutologous stem cell therapy ( Lifecells LLC)

Drug Alias NameASCT-01

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsIschemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesLifecells Llc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesLifecells Llc

Active IndicationsN/A

Inactive IndicationsIschemia

Other Information

ATC CodeN/A